BeStock  
Stocks › Biotechnology › SRPT

Sarepta Therapeutics SRPT

US equityMarket cap rank #2908Biotechnology
$13.33 −$0.84 (-5.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.60 +2.03%
Open$13.92
Prev close$14.17
Day range$13.25 – $14.47
Volume2.25M
Market cap$1.43B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership98.1%-4.79 pts vs. prior quarter
Institutions holding385-6 vs. prior quarter
Insider trades (recent)26 buys / 24 sellsNet buying
Short interest18.27% of floatDays to cover 7.8 · as of 30 Oct 2026
Short-sale volume share21.0%5-day average of daily volume

Short-sale volume as % of daily volume

12%20%28%36%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.65M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$3.3MSuper−$2.4MBig−$406.8KMid−$677.3KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.1% of shares outstanding.

Largest holders

  • BlackRock17.51%
  • Vanguard Portfolio Management, LLC8.11%
  • State Street Global Advisors6.91%
  • Vanguard Capital Management, LLC4.29%
  • Two Sigma Investments, LP4.29%
  • First Trust Advisors L.P.4.07%
  • AQR Capital Management3.98%
  • Richard Barry3.00%

By investor type

  • Mutual Fund70.72%
  • Hedge Fund17.51%
  • Public Company5.80%
  • Individual/Insider4.70%
  • Private Company1.56%
  • Government Pension Fund1.44%
  • Insurance Company0.49%
  • VC/PE Fund0.45%

Reported short interest has fallen from 25.61% to 18.27% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Pictet Asset Management Limited Mutual Fund 2026/Q3 +674,250 0.6%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +557,069 4.6%
FMR Mutual Fund 2026/Q3 +436,859 0.6%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +394,816 1.0%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +320,053 8.1%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +301,752 0.6%
PanAgora Asset Management, Inc. Mutual Fund 2026/Q3 +248,351 0.7%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +190,750 0.9%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +415,295 0.4%
BlackRock Mutual Fund 2026/Q3 +4,239,681 18.0%
State Street Global Advisors Mutual Fund 2026/Q3 +2,302,776 8.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,736,778 7.9%
Marshall Wace LLP Hedge Fund 2026/Q3 +1,480,954 2.1%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +782,962 2.6%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +609,796 0.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Sep 2026 Louise Rodino-Klapac President of Research & Development and Technical Operations Sale to Issuer -21,423 $22.22 203,900
3 Sep 2026 Ian Estepan President Sale to Issuer -24,799 $22.22 177,184
3 Sep 2026 Cristin Rothfuss Sale to Issuer -22,025 $22.22 115,519
3 Sep 2026 Ryan Wong Chief Financial Officer Sale to Issuer -13,272 $22.22 121,792
27 Jul 2026 Michael Severino Chief Executive Officer Other Acquisition +756,104 – 756,104
27 Jul 2026 Michael Severino Chief Executive Officer Other Derivative Acquisition +2,224,342 $17.74 2,224,342
3 Jun 2026 M. Behrens Wilsey Independent Chairwoman Other Acquisition +16,875 – 16,875
3 Jun 2026 Hans Wigzell Chairman of Corporate Strategy Board & Independent Non-Employee Director Other Acquisition +16,875 – 16,875
3 Jun 2026 Richard Barry Independent Director Other Acquisition +16,875 – 16,875
3 Jun 2026 Michael Chambers Independent Director Other Acquisition +16,875 – 16,875
3 Jun 2026 Deirdre Connelly Independent Director Other Acquisition +16,875 – 18,770
3 Jun 2026 Stephen Mayo Independent Director Other Acquisition +16,875 – 16,875
3 Jun 2026 Claude Nicaise Independent Director Other Acquisition +16,875 – 16,875
3 Jun 2026 Kathryn Boor Independent Director Other Acquisition +16,875 – 16,875
11 Mar 2026 Stephen Mayo Independent Director Open Market Disposition -7,239 $17.02 1,765
10 Mar 2026 Louise Rodino-Klapac President of Research & Development and Technical Operations Sale to Issuer -948 $17.03 225,323
10 Mar 2026 Ian Estepan President Sale to Issuer -1,097 $17.03 201,983
10 Mar 2026 Cristin Rothfuss Sale to Issuer -974 $17.03 137,544
10 Mar 2026 Ryan Wong Chief Financial Officer Sale to Issuer -256 $17.03 135,064
8 Mar 2026 Louise Rodino-Klapac President of Research & Development and Technical Operations Sale to Issuer -1,399 $16.95 226,271

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 19,297,522 18.3% 7.8
15 Oct 2026 22,330,342 21.1% 7.5
30 Sep 2026 22,784,187 21.6% 8.6
15 Sep 2026 25,434,681 24.1% 8.0
31 Aug 2026 24,621,090 23.3% 8.5
14 Aug 2026 27,049,885 25.6% 9.1

Discussion

No comments yet — be the first to weigh in on SRPT.

Sign in to join the discussion.

Scroll to Top